Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment [Phase 3]
A Phase 3 trial comparing Niraparib-TSR-042 (Dostarlimab) to physician's choice chemotherapy in recurrent ovarian/fallopian tube/primary per…
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination [Phase 1, Phase 2]
A phase 1/2 trial comparing carboplatin-paclitaxel-bevacizumab with alternative regimens including rucaparib, selected by HRD status, in adv…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients [Phase 3]
Phase 3 trial comparing trabectedin (ET-743) to clinician's choice chemotherapy in recurrent ovarian, primary peritoneal, or fallopian tube …
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab in combination with pegylated liposomal doxorubicin for recurrent platinum-resistant ovarian, fallo…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC [Phase 2]
Phase 2 clinical trial evaluating efficacy and safety of SG001 in combination with PLD for platinum-resistant relapsed epithelial ovarian ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) [Phase 2]
Phase 2 study ARIEL2 evaluating rucaparib in platinum-sensitive relapsed high-grade ovarian/fallopian tube/primary peritoneal cancer complet…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for DPX-Survivac in recurrent ovarian-related cancers, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal infusion of autologous monocytes with Sylatron (peginterferon alfa-2b) and Actimmune (interferon ga…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? [Phase 3]
Phase 3 trial comparing surgery versus chemotherapy in recurrent ovarian cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating guadecitabine plus pembrolizumab in recurrent ovarian, primary peritoneal, or fallopian tube cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 study evaluating oral gimatecan in platinum-resistant epithelial ovarian cancer and related abdominal cancers is ongoing with unknow…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel, polyglutamate paclitaxel, or observation in advanced ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update comparing olaparib alone or the combination of cediranib plus olaparib against standard chemotherapy in platinum-sensit…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A phase 3 trial compares olaparib alone or the combination of cediranib and olaparib versus standard chemotherapy for women with platinum-se…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer [Phase 2]
Phase 2 randomized study evaluating safety and efficacy of Pazopanib plus Gemcitabine in persistent or relapsed ovarian cancer (and related …
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Neoadjuvant Therapy for Ovarian Cancer [Phase 2]
Phase 2 neoadjuvant therapy trial for epithelial ovarian cancer with involvement of primary peritoneal cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations [Phase 1, Phase 2]
Pilot trial of BMN 673 (olaparib) in advanced solid tumors with deleterious BRCA mutations completed phases 1 and 2; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy plus cetuximab in patients with peritoneal carcinomatosis from colorectal cancer undergoing surgery; t…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating enzastaurin for persistent or recurrent ovarian or primary peritoneal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluates whether adding bevacizumab to a carboplatin, paclitaxel, and gemcitabine regimen after surgery improves outcome…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) [Phase 1, Phase 2]
Phase I/II study of oral rucaparib in patients with BRCA-mutant ovarian cancer and to a lesser extent solid tumors; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]
Phase 2 trial of anti-PD-L1 therapy with SAbR (stereotactic ablative radiotherapy) in recurrent epithelial ovarian/fallopian tube/primary pe…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 trial comparing PankoMab-GEX as maintenance therapy to placebo in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating veliparib with carboplatin/paclitaxel and continuation maintenance in newly diagnosed stage III/IV high-grade ser…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial update reporting results for nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian, fallopian …